Work

A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer

Year: 2013

Type: article

Study design: Clinical Trial

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-013-2960-3

Authors: D. Magge, A. H. Zureikat, D. L. Bartlett, M. P. Holtzman, H. A. Choudry, J. H. Beumer, J. F. Pingpank, J. L. Holleran, S. Strychor, D. E. Cunningham, H. L. Jones, H. J. Zeh

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis, University of Pittsburgh Clinical and Translational Science Institute, Cancer Center Support Grant, Postdoctoral Research Training in Biotherapy of Cancer

OpenAlex ID: W2023113445

FWCI: 0.503

Cites: 37

Cited by: 9

Related to: 10